EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.
Clicks: 40
ID: 277256
2023
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.6
/100
2 views
2 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Supplementary file1 (MP4 21169 KB).
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (4 words).
Try re-searching for a better abstract.
Reference Key |
le2023egfrtargeted
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Le, Xiuning;Nadler, Eric;Costa, Daniel B;Heymach, John Victor; |
Journal | Targeted oncology |
Year | 2023 |
DOI | 10.1007/s11523-023-00994-2 |
URL | |
Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.